LivingGLP1
crossover randomized trial

NCT01562678

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Design

Randomized
28
Start year
2012
Treatment
2.43 weeks
Countries
United States (1 sites)
Sponsor
Beth Israel Deaconess Medical Center (mixed)
Eligibility
adults with type 2 diabetes on lifestyle or metformin

Conduct and analysis

Blinding
double blind
Sequence generation
other adequate
Allocation concealment
pharmacy or sealed
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
completers
Missing data
none

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Placebo
Placebo
lifestyle or metformin; lifestyle: not reported2818
A2Liraglutide 1.8 mg subcutaneous once daily
Liraglutide 1.8 mg
lifestyle or metformin; lifestyle: not reported2818

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticPlacebo
A1
Liraglutide 1.8 mg subcutaneous once daily
A2
Whole trial
ALL
agemean (years)52.5
agesd (years)10.5
bmimean (kg/m2)31.231.9
bmise (kg/m2)1.71.7
femalen12
waistmean (cm)105.1106.8
waistse (cm)3.53.5
weightmean (kg)93.494.7
weightse (kg)4.84.7

Results

12 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
HbA1c change (2 lines; O01)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
2.43A1final6.7 percent0.218not stated; completers; R0022856:Table 2
2.43A2final6.7 percent0.218not stated; completers; R0022856:Table 2
Body weight change in kilograms (diabetes) (2 lines; O02)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
2.43A1final91.1 kg1.018not stated; completers; R0022856:Table 2
2.43A2final91.0 kg1.018not stated; completers; R0022856:Table 2
All cause mortality (2 lines; O20)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 28not stated; safety; registry:adverse_events
A2events0 / 28not stated; safety; registry:adverse_events
Serious adverse events (2 lines; O25)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 28not stated; safety; registry:adverse_events
A2events0 / 28not stated; safety; registry:adverse_events
Nausea (2 lines; O27A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events7 / 18not stated; other; R0022856:Results
A2events7 / 18not stated; other; R0022856:Results
Death by suicide (2 lines; O35B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 28not stated; safety; registry:adverse_events
A2events0 / 28not stated; safety; registry:adverse_events